Latest Brooks Laboratories stock price
Brooks Laboratories P/E Ratio
BROOKS • P/E ratio not applicable due to negative earnings
P/E Ratio Status
N/A
Loss Making
Company is currently reporting losses
P/E Ratio Not Applicable
Company reported a loss in the most recent quarter. P/E ratio is not meaningful for loss-making periods.
Current EPS: ₹-3.72
Recent Quarterly Performance
| Quarter | EPS (₹) | Net Profit (₹ Cr) | Status |
|---|---|---|---|
| Sept 2025 | 2.71 | 8 | Profit |
| Mar 2025 | -0.54 | -2 | Loss |
| Jun 2025 | 3.25 | 10 | Profit |
| Sept 2024 | -1.51 | -4 | Loss |
| Mar 2024 | -3.77 | -10 | Loss |
| Jun 2024 | -0.94 | -2 | Loss |
| Dec 2024 | -1.75 | -2 | Loss |
| Sept 2023 | -0.60 | -2 | Loss |
Profitable Companies in Healthcare Sector
Other profitable companies in Healthcare sector with valid P/E ratios
Sector Average PE
53.68
Sector Median PE
31.12
Lowest PE
1.5
Profitable Companies
131
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.5 | ₹51 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 3.18 | ₹733 | Low |
| Murae Organisor | MURAE | 3.86 | ₹55 | Low |
| Fermenta Biotech | FERMENTA | 9.01 | ₹1,010 | Low |
| Zenith Drugs | ZENITHDRUG | 9.06 | ₹84 | Low |
| Galaxy Medicare | GML | 9.5 | ₹32 | Low |
| Balaxi Pharmaceuticals | BALAXI | 10.06 | ₹139 | Low |
| Natco Pharma | NATCOPHARM | 10.8 | ₹17,006 | Low |
| Vasundhara Rasayans | VRL | 11.3 | ₹51 | Low |
| Mohini Health & Hygiene | MHHL | 11.84 | ₹69 | Low |